Comparing Byetta vs Mounjaro
Byetta (exenatide) | Mounjaro (tirzepatide) |
|
---|
Byetta (exenatide) | Mounjaro (tirzepatide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Type 2 Diabetes. Byetta may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Related suggestions Type 2 Diabetes
|
|||||||||||||||
More about Byetta (exenatide) | More about Mounjaro (tirzepatide) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Byetta has an average rating of 7.8 out of 10 from a total of 82 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 12% reported a negative effect. |
Mounjaro has an average rating of 8.5 out of 10 from a total of 1359 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Byetta side effects |
View all Mounjaro side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic approved | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Byetta prices |
View all Mounjaro prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other exenatide brands include: Bydureon, Bydureon BCise | Other tirzepatide brands include: Zepbound | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
2.4 hours |
120 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 373 drugs are known to interact with Byetta:
|
A total of 414 drugs are known to interact with Mounjaro:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
April 28, 2005 |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.